GlassScriptPhysician profile
Jeffrey D Nations
NPI 1811327851
$2,994.42
in general payments reported to CMS, 2019-2025
30 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $231 · 2021: $298 · 2022: $360 · 2023: $285 · 2024: $265 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $613.35 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $403.06 | 2021-2025 | |
| Lilly USA, LLC | $392.11 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $203.45 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $188.86 | 2019-2025 | Breztri, Airsupra |
| Novartis Pharmaceuticals Corporation | $162.68 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $110.78 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $101.97 | 2020-2023 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $79.59 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Exact Sciences Corporation | $76.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.23 | 2019-2023 | Synjardy, Jardiance, Tradjenta |
| Amgen INC. | $65.65 | 2019-2024 | Repatha, Otezla |
| Amarin Pharma, INC. | $58.87 | 2020-2021 | |
| Alkermes, INC. | $54.74 | 2025 | Lybalvi |
| Sanofi-Aventis U.S. LLC | $51.81 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $48.13 | 2019-2020 | |
| Abbott Laboratories | $40.67 | 2020-2021 | |
| Axsome Therapeutics, INC. | $36.69 | 2024 | Auvelity |
| Organon LLC | $33.95 | 2022-2023 | Nexplanon |
| Dexcom, INC. | $26.11 | 2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $23.62 | 2022 | |
| Vanda Pharmaceuticals INC. | $21.60 | 2024 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $21.36 | 2023 | Abilify Maintena, Rexulti |
| Almatica Pharma LLC | $19.44 | 2021 | |
| Hologic Sales and Service, LLC | $17.76 | 2024 | Thinprep 2000 Processor, Aptima |
| Phathom Pharmaceuticals, INC. | $14.47 | 2025 | Voquezna |
| Sanofi Pasteur INC. | $14.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.61 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Nations listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.